Price (delayed)
$571.44
Market cap
$8.6B
P/E Ratio
28.66
Dividend/share
$1.7
EPS
$19.94
Enterprise value
$8.52B
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of
Highlights
The net income has grown by 33% year-on-year and by 6% since the previous quarter
The EPS has increased by 32% YoY and by 6% from the previous quarter
Chemed's quick ratio has soared by 68% YoY but it has decreased by 10% from the previous quarter
The debt is up by 3.9% year-on-year
Key stats
What are the main financial stats of CHE
Market
Valuations
Earnings
Shares outstanding
15.05M
Market cap
$8.6B
Enterprise value
$8.52B
Price to earnings (P/E)
28.66
Price to book (P/B)
7.17
Price to sales (P/S)
3.69
EV/EBIT
21.92
EV/EBITDA
18.89
EV/Sales
3.65
Revenue
$2.34B
EBIT
$388.81M
EBITDA
$451.25M
Free cash flow
$256.09M
Per share
Balance sheet
Liquidity
EPS
$19.94
Free cash flow per share
$16.96
Book value per share
$79.75
Revenue per share
$154.7
TBVPS
$64.64
Total assets
$1.73B
Total liabilities
$527.69M
Debt
$146.4M
Equity
$1.21B
Working capital
$202.86M
Debt to equity
0.12
Current ratio
1.78
Quick ratio
1.56
Net debt/EBITDA
-0.17
Margins
Efficiency
Dividend
EBITDA margin
19.3%
Gross margin
36%
Net margin
12.9%
Operating margin
15.4%
Return on assets
18%
Return on equity
26.6%
Return on invested capital
66.4%
Return on capital employed
26.4%
Return on sales
16.6%
Dividend yield
0.3%
DPS
$1.7
Payout ratio
8.5%
CHE stock price
How has the Chemed stock price performed over time
Intraday
-0.41%
1 week
-2.51%
1 month
-0.75%
1 year
14.03%
YTD
-2.28%
QTD
5.32%
Financial performance
How have Chemed's revenue and profit performed over time
Revenue
$2.34B
Gross profit
$839.98M
Operating income
$358.7M
Net income
$300.92M
Gross margin
36%
Net margin
12.9%
The net income has grown by 33% year-on-year and by 6% since the previous quarter
The net margin is up by 24% year-on-year and by 4% since the previous quarter
Chemed's operating income has increased by 18% YoY and by 5% from the previous quarter
CHE's gross profit is up by 13% year-on-year and by 3.3% since the previous quarter
Growth
What is Chemed's growth rate over time
Valuation
What is Chemed stock price valuation
P/E
28.66
P/B
7.17
P/S
3.69
EV/EBIT
21.92
EV/EBITDA
18.89
EV/Sales
3.65
The EPS has increased by 32% YoY and by 6% from the previous quarter
The price to earnings (P/E) is 9% lower than the last 4 quarters average of 31.4
Chemed's equity has increased by 27% YoY and by 2% from the previous quarter
The P/B is 23% less than the 5-year quarterly average of 9.3 and 7% less than the last 4 quarters average of 7.7
The revenue rose by 7% year-on-year
CHE's P/S is 2.9% below its last 4 quarters average of 3.8 but 2.5% above its 5-year quarterly average of 3.6
Efficiency
How efficient is Chemed business performance
The company's return on invested capital rose by 21% YoY
The ROS has increased by 19% YoY and by 4.4% from the previous quarter
The ROA rose by 14% year-on-year and by 2.9% since the previous quarter
Dividends
What is CHE's dividend history
DPS
$1.7
Dividend yield
0.3%
Payout ratio
8.5%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Chemed financials performed over time
Chemed's quick ratio has soared by 68% YoY but it has decreased by 10% from the previous quarter
CHE's current ratio has soared by 60% YoY but it is down by 7% from the previous quarter
The debt is 88% smaller than the equity
Chemed's equity has increased by 27% YoY and by 2% from the previous quarter
CHE's debt to equity is down by 20% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.